|
|
Poster: 658
Visits: 209
Title: JTZ-951, A NOVEL HIF-PHD INHIBITOR, DEMONSTRATES INCREASES IN HEMOGLOBIN, IRON MOBILIZATION, REPRODUCIBLE PHARMACOKINETICS, AND SAFETY FOLLOWING ONCE DAILY ADMINISTRATION FOR 15 DAYS IN PATIENTS WITH ANEMIA RECEIVING HEMODIALYSIS
Authors: Sudhakar Pai , R. Koretomo, S. Tamaki, J. Berg, T. Marbury, C. Galloway, R. Preston
Centre: Akros Pharma, Inc.
|
|